AI주식인사이트AI Stock Insight
C

지에프씨생명과학

388610KOSDAQ기타 화학제품 제조업

48.3 / 100

Reference Date: 2026-07-24

Financial Score8.0 / 40
News Sentiment21.3 / 25
Momentum9.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk, PER raises overvaluation concerns. Rose 13.6% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

GFCC Life Sciences operates two main business units: the Material Business Unit, which develops innovative cosmetic ingredients using skin microbiome and exosome technologies, and the Clinical Business Unit, which provides human efficacy testing services for cosmetics. The Material Business Unit leverages a library of over 2,000 strains and proprietary patents to produce high-value raw materials, expanding into the growing skin booster market. The Clinical Business Unit benefits from increased demand for efficacy verification due to regulatory changes, driving sustained revenue growth.

Number of Employees

86people

Average Salary

47.9M KRW

Score Calculation Basis

Detailed Financial Score

PER
52.17Industry Average 16.670.0Point

3.1x industry avg (risky)

PBR
1.34Industry Average 1.062.5Point

Higher than industry avg (caution)

ROE
3.20Industry Average 4.552.5Point

Below industry avg

Debt Ratio
33.67Industry Average 8.130.0Point

4.1x industry avg (risky)

Trend 2024~20253.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲5.4% (1-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼77.3% (1-year basis)

ROE Trend
1.0 / 4

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (8%, downtrend)

Current 6,000Won52-week high 21,95052-week low 4,600
1-month return5.0Point

1m +13.64% (rising)

Volume trend3.0Point

Volume flat

Detailed Disclosure

9 totalPositive 0Neutral 9Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-07-23
  • Neutral자기주식처분결과보고서2026-07-23
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-23
  • Neutral주요사항보고서(자기주식처분결정)2026-07-20
  • Neutral주식매수선택권부여에관한신고2026-07-20